Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

Trial Profile

Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Feb 2014

At a glance

  • Drugs Omeprazole/sodium bicarbonate (Primary)
  • Indications Gastrointestinal haemorrhage
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Salix Pharmaceuticals
  • Most Recent Events

    • 10 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top